Explore more publications!

Latest News

Labels On
FILTER THE FEED
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
FILTER THE FEED
Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Great Place To Work™ Greater China Celebrates the Best Workplaces™ in Greater China 2025

Great Place To Work™ Greater China Celebrates the Best Workplaces™ in Greater China 2025

Indeterminate The Laotian Times
Owner: Cameron Darke, Aditta Kittikhoun & Jason Rolan
Bristol Myers Squibb's Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma

Bristol Myers Squibb's Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma

Neutral Investing News Network
Owner: Nick Smith
Corruption, Donald Trump and the Swiss

Corruption, Donald Trump and the Swiss

Construction projects moving forward across New Bern, from new housing to hotel progress

Construction projects moving forward across New Bern, from new housing to hotel progress

Rory Hearne: The social contract for renters has been ripped up - to traumatic effect

Rory Hearne: The social contract for renters has been ripped up - to traumatic effect

Center-left The Journal
Owner: Eamon & Brian Fallon
Corruption, Donald Trump and the Swiss

Corruption, Donald Trump and the Swiss

Construction projects moving forward across New Bern, from new housing to hotel progress

Construction projects moving forward across New Bern, from new housing to hotel progress

Rory Hearne: The social contract for renters has been ripped up - to traumatic effect

Rory Hearne: The social contract for renters has been ripped up - to traumatic effect

Great Place To Work™ Greater China Celebrates the Best Workplaces™ in Greater China 2025

Great Place To Work™ Greater China Celebrates the Best Workplaces™ in Greater China 2025

Bristol Myers Squibb's Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma

Bristol Myers Squibb's Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma

Show More

Video Stories

YouTube video thumbnail: EU Updates Asylum Guidance for Syrian Refugees a Year After Fall of Bashar al-Assad
Play
EU Updates Asylum Guidance for Syrian Refugees a Year After Fall of Bashar al-Assad
YouTube video thumbnail: Ukraine Tells Russia to Stop Wasting the World's Time, With no end to war in Sight
Play
Ukraine Tells Russia to Stop Wasting the World's Time, With no end to war in Sight
YouTube video thumbnail: Using Frozen Russian Assets to Fund Ukraine "the Only Viable Option", Says Dutch FM
Play
Using Frozen Russian Assets to Fund Ukraine "the Only Viable Option", Says Dutch FM
YouTube video thumbnail: Hungary Challenges EU ban on Russian gas Imports: DW Speaks to EU's Dan Jørgensen
Play
Hungary Challenges EU ban on Russian gas Imports: DW Speaks to EU's Dan Jørgensen

Video Title

Press Releases

Treasury invites media to Pre-World Economic Forum (WEF) Annual Meeting breakfast in Johannesburg, 8 Dec

Treasury invites media to Pre-World Economic Forum (WEF) Annual Meeting breakfast in Johannesburg, 8 Dec

Treasury invites media to Pre-World Economic Forum (WEF) Annual Meeting breakfast in Johannesburg, 8 Dec

Treasury invites media to Pre-World Economic Forum (WEF) Annual Meeting breakfast in Johannesburg, 8 Dec

Show More
Your brand’s story is being written — with or without you.
We’re the leading press release service for mid-sized businesses & organizations built for the AI era.
Learn more

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions